Zion Market Research has published a new report titled “Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X-Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis And Forecast, 2015 – 2021” According to the report, the global clinical trial imaging market was valued at approximately USD 731.9 million in 2015 and is expected to reach approximately USD 1,052.9 million by 2021, growing at a CAGR of around 6.30% between 2016 and 2021.
Imaging is the technique of generating visual representations of an object or body. Clinical trial imaging uses imaging technology in clinical trials for viewing the interior parts of the body. The images obtained from clinical trial imaging are used for diagnosing, examine and reveal the human body. Screening imaging clinical trials, diagnostic imaging clinical trials, and image-guided interventional clinical trials are the key types include in clinical trial imaging. Clinical trial imaging provides quick, detail, accurate diagnosis.
Request for Free Sample Report: http://www.marketresearchstore.com/report/clinical-trial-imaging-market-z59874#RequestSample
Increasing geriatric population and growing occurrences of chronic diseases are some of the major factors driving the clinical trials imaging market. Growth in the pharmaceutical industry is a major factor that is expected to help the growth of the clinical trial imaging in the years to come. Government support and investments coupled with research and development activities especially in countries such as U.S. and UK is anticipated to boost the market growth in the near future. However, the high cost of machinery and its installation is a major restraining factor for the market growth.
Request For Free Price Quotation: http://www.marketresearchstore.com/requestquote?reportid=59874
The clinical trial imaging market is segmented on the basis of service and software. Service accounted for a large chunk of the global clinical trial imaging market in 2015. Software is another leading segment and it accounted for 35.2% share of the total market in 2015. This growth is mainly attributed to high investment in R&D activities coupled with government support.
Based on technology, the global clinical trial imaging market is segmented as echo, PET, MRI, X-Ray, CT, and ultrasound and others. The CT segment dominated the market with over 31.0% share of the total market in 2015. MRI, PET, and ultrasound are also accounted for significant share owing to the increasing disabled and aging populations who are commonly diagnosed with the different disease and other complications.
Browse the full report at http://www.marketresearchstore.com/report/clinical-trial-imaging-market-z59874
Some of the key end-users of the clinical trial imaging market include biotech companies, pharmaceutical, research centers, hospitals and others. Among all end-users, pharmaceutical was the leading segment and it accounted for over 45.0% share of the total revenue generated in 2015. Biotech companies another key outlet of the market and expected to exhibit significant growth within the forecast period. This growth is mainly due to rising development in bio-pharmaceutical industries.
North America dominated the clinical trial imaging market and accounted for over 44.0% share of the global market in 2015. North America was followed by Europe in terms of revenue. The clinical trial imaging market in Asia-Pacific region is expected to exhibit significant growth owing to rising government support and rapid growth in population. Latin America and Middle East & Africa are also expected to experience significant growth of clinical trial imaging market in the years to come.
Some of the key players of the global clinical trial imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.
This report segments the global clinical trial imaging market as follows:
Product Segment Analysis: Service, Software
Technology Segment Analysis: X-ray, CT, MRI, PET, Echo, Ultrasound, Other technologies
End user Segment Analysis: Biotech companies, Pharmaceutical, Research Centers, Hospitals, Other end users
Regional Segment Analysis: North America(U.S.), Europe(UK, France, Germany), Asia-Pacific(China, Japan, India), Latin America(Brazil), Middle East and Africa
Visit Our Blog: https://marketresearchstore2017.wordpress.com
About Us: Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
3422 SW 15 Street, Suit #8138
Deerfield Beach, Florida 33442
Toll Free: +1-855-465-4651 (USA-CANADA)